SHANNON SMOTHERS: Open Payments
NPI 1639428147 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,634 in 95 payments from 17 companies in 2025. Trend: 2023 $1,793 · 2024 $1,685 · 2025 $1,634
Food & beverage: $1,634
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $282 |
| ABBVIE INC. | 24 | $271 |
| Abbott Laboratories | 10 | $198 |
| Lilly USA, LLC | 10 | $179 |
| PFIZER INC. | 10 | $169 |
| Axsome Therapeutics, Inc. | 5 | $148 |
| Amgen Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| SANOFI-AVENTIS U.S. LLC | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, Wegovy, VRAYLAR, Ozempic, Auvelity, NURTEC ODT, EVENITY.
Industry payments across TX — which companies pay providers there.
